A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC
NACompletedINTERVENTIONAL
Enrollment
112
Participants
Timeline
Start Date
Not specified
Study Completion Date
September 30, 1991
Conditions
HIV Infections
Interventions
DRUG
Zidovudine
DRUG
Zalcitabine
Trial Locations (1)
60611
Northwestern University CRS, Chicago
All Listed Sponsors
collaborator
Hoffmann-La Roche
INDUSTRY
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000718 - A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC | Biotech Hunter | Biotech Hunter